Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2009

View Archived Issues

Phase II trials of JNJ-42160443 in various types of pain are under way

Potent in vitro antiviral activity of enterovirus capsid inhibitor V-073 supports future development

Roche presents results from third quarter of 2009

Recombinant adenovirus serotype 26 HIV-1 vaccine safe, immunogenic in humans

Canakinumab trials show efficacy in juvenile idiopathic arthritis and gouty arthritis

Pharming reports results from preclinical study of rhC1INH in ischemic brain injury

Phase I trial of recombinant human acid sphingomyelinase in type B Niemann-Pick disease reported

In vivo evaluation of the novel nAChR agonist PF-4888086 in models of antipsychotic activity

EMEA grants positive opinion for The Medicines Company's Angiox in PCI

MedImmune reports interim data from ongoing trials of LAIV 2009 H1N1 vaccine

Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer

Eisai and TSD Japan enter into agreement for denileukin diftitox in Japan

SuperGen and GSK to collaborate on novel epigenetic therapeutics

CXCR3 antagonists claimed by sanofi-aventis for rheumatoid arthritis

Janssen discloses MC-5 receptor ligands for treatment of dermatological conditions

Ohio State University developing AR ablating agents for treating prostate cancer

Cephalon to acquire BioAssets Development Corporation

Astellas terminates development of antihuman osteopontin antibody ASK-8007 in RA

Ablynx wins award for successfully progressing antithrombotic ALX-0081 to phase II

PTC Therapeutics initiates phase II clinical trial of ataluren in hemophilia

FDA committee to review Gilead's aztreonam for P. aeruginosa infection in CF

FDA grants emergency use authorization to BioCryst's peramivir for 2009 H1N1 influenza

Psynova Neurotech and RBM identify diagnostic biomarkers for schizophrenia

FDA grants marketing clearance to Axis-Shield's anti-CCP assay in RA

Prometheus Laboratories launches ProOncDx diagnostic cancer tests in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...